Cholesterol ensures ciliary polycystin-2 localization to prevent polycystic kidney disease
The plasma membrane covering the primary cilium has a diverse accumulation of receptors and channels. To ensure the sensor function of the cilia, the ciliary membrane has higher cholesterol content than other cell membrane regions. A peroxisomal biogenesis disorder, Zellweger syndrome, characterized by polycystic kidney, is associated with a reduced level of ciliary cholesterol in cells. However, the etiological mechanism by which ciliary cholesterol lowering causes polycystic kidney disease remains unclear. Here, we demonstrated that lowering ciliary cholesterol by either pharmacological treatment or genetic depletion of peroxisomes impairs the localization of a ciliary ion channel polycystin-2. We also generated cultured renal medullary cells and mice carrying a missense variant in the cholesterol-binding site of polycystin-2 detected in the patient database of autosomal dominant polycystic kidney disease. This missense protein showed normal channel activity but decreased localization to the ciliary membrane. The homozygous mice exhibited embryonic lethality and the ciliopathy spectrum conditions of situs inversus and polycystic kidney. Our results suggest that cholesterol controls the ciliary localization of polycystin-2 to prevent polycystic kidney disease.
Authors
- Moe Hirosawa
- Kenji Yamaoka (ORCID: https://orcid.org/0000-0002-8896-3455)
- Takeshi Itabashi (ORCID: https://orcid.org/0000-0001-6985-4539)
- Hiroko Kishi (ORCID: https://orcid.org/0000-0003-2896-7355)
- Hideshi Kawakami (ORCID: https://orcid.org/0000-0002-1405-0901)
- Tatsuo Miyamoto (ORCID: https://orcid.org/0000-0002-1097-0647)
- Kodai Kume (ORCID: https://orcid.org/0000-0001-9266-2543)
- Kouichi Hashimoto (ORCID: https://orcid.org/0000-0002-3884-8213)
- Kosuke Hosoba (ORCID: https://orcid.org/0000-0002-6652-6385)
- Sotai Kimura
- Takashi Yamamoto (ORCID: https://orcid.org/0000-0002-6516-2903)
- Daigo Kobayashi
- Hiroshi Itoh (ORCID: https://orcid.org/0000-0001-5793-0186)
- Tomoka Morita
Institutions
- Hiroshima University (JP)
- Shimane University (JP)
- Yamaguchi University (JP)
- Hirosaki University Hospital (JP)
Publication Details
- Journal
- Life Science Alliance
- Published
- 2025-02-03
- DOI
- https://doi.org/10.26508/lsa.202403063
- Citations
- 4
- Primary Topic
- Genetic and Kidney Cyst Diseases
- Type
- article
- Field-Weighted Citation Impact
- 7.27
Funders
- Japan Agency for Medical Research and Development
- Ministry of Education, Culture, Sports, Science and Technology
- Astellas Pharma
- Astellas Foundation for Research on Metabolic Disorders
- Chugai Pharmaceutical
- Japan Society for the Promotion of Science